5Shin K E, Ahn K J, Choi H S, et al. Dce and Dsc MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma[J]. Clin Radiol, 2014, 69(6): e264-e272. 被引量：1
6Smith D S, Li X, Gambrell J V, et al. Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI[J]. IEEE Trans Med Imaging, 2012, 31(2): 504-511. 被引量：1
7Jung S C, Yeom J A, Kim J H, et al. Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading[J]. AJNR Am J Neuroradiol, 2014, 35(6): 1103-1110. 被引量：1
8Sourbron S. Technical aspects of MR perfusion[J]. Eur J Radiol, 2010, 76(3): 304-313. 被引量：1
9Bonekamp D, Deike K, Wiestler B, et al. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1- and T*2 -based bolus techniques[J]. J Magn Reson Imaging, 2014, [Epub ahead of print]. 被引量：1
10Falk A, Fahlstrom M, Rostrup E, et al. Discrimination between glioma grades Ⅱ and Ⅲ in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach[J]. Neuroradiology, 2014, 56(12): 1031-1038. 被引量：1
